Jianmin Fang

机构：Yantai University, Yantai Academy of Agricultural Sciences

发表论文 27 篇 · 总被引 448 次 · h-index 10

代表论文

• The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors (2024 · Journal of Hematology & Oncology · 被引 156)
• A HER2‐targeted Antibody‐Drug Conjugate, RC48‐ADC, Exerted Promising Antitumor Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer (2023 · Advanced Science · 被引 46)
• A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis (2024 · European Journal of Neurology · 被引 42)
• RC48-ADC for metastatic urothelial carcinoma with HER2-positive: Combined analysis of RC48-C005 and RC48-C009 trials. (2022 · Journal of Clinical Oncology · 被引 33)
• Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma (2023 · npj Precision Oncology · 被引 19)
• ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma (2023 · iScience · 被引 15)